Диссертация (Влияние компонентов сигнального пути HEDGEHOG на пролиферацию и химиорезистентность низкодифференцированных глиом), страница 25
Описание файла
Файл "Диссертация" внутри архива находится в папке "Влияние компонентов сигнального пути HEDGEHOG на пролиферацию и химиорезистентность низкодифференцированных глиом". PDF-файл из архива "Влияние компонентов сигнального пути HEDGEHOG на пролиферацию и химиорезистентность низкодифференцированных глиом", который расположен в категории "". Всё это находится в предмете "биология" из Аспирантура и докторантура, которые можно найти в файловом архиве РНИМУ им. Пирогова. Не смотря на прямую связь этого архива с РНИМУ им. Пирогова, его также можно найти и в других разделах. , а ещё этот архив представляет собой кандидатскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени кандидата биологических наук.
Просмотр PDF-файла онлайн
Текст 25 страницы из PDF
J. Stromal response to Hedgehog signaling restrains pancreatic cancer progression / J. J.Lee, R. M. Perera, H. Wang et al. // Proc Natl Acad Sci U S A. – 2014. – Vol. 111. – № 30. – P.E3091-100.140. Wang, Y. The Role of Snail in EMT and Tumorigenesis / Y. Wang, J. Shi, K. Chai et al. // CurrCancer Drug Targets.
– 2013. – Vol. 13. – № 9. – P. 963-972.141. Lo, H. W. Epidermal growth factor receptor cooperates with signal transducer and activator oftranscription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation ofTWIST gene expression / H. W.
Lo, S. C. Hsu, W. Xia et al. // Cancer Res. – 2007. – Vol. 67. –№ 19. – P. 9066-76.142. Liao, X. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect onprognosis, cell invasion and differentiation / X. Liao, M. K. Siu, C. W. Au et al. //Carcinogenesis. – 2009.
– Vol. 30. – № 1. – P. 131-40.113143. Zheng, X. CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma / X. Zheng, T. Song, C. Dou et al. //Oncotarget. – 2015. – Vol. 6. – № 6. – P. 3752-69.144. Li, X. Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin / X.Li, W. Deng, S. M. Lobo-Ruppert et al. // Oncogene. – 2007. – Vol.
26. – № 31. – P. 4489-98.145. Liao, X. Aberrant activation of hedgehog signaling pathway contributes to endometrialcarcinogenesis through beta-catenin / X. Liao, M. K. Siu, C. W. Au et al. // Mod Pathol. – 2009.– Vol. 22. – № 6. – P. 839-47.146. Xu, X. Genome-wide screening reveals an EMT molecular network mediated by Sonichedgehog-Gli1 signaling in pancreatic cancer cells / X. Xu, Y. Zhou, C. Xie et al. // PLoS One.
–2012. – Vol. 7. – № 8. – P. e43119.147. Xu, X. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition(EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells / X. Xu, B. Su, C. Xieet al. // PLoS One. – 2014. – Vol. 9. – № 7. – P. e96441.148. Choe, J. Y. Sonic hedgehog signalling proteins are frequently expressed in retinoblastoma andare associated with aggressive clinicopathological features / J. Y.
Choe, J. Y. Yun, Y. K. Jeon etal. // J Clin Pathol. – 2015. – Vol. 68. – № 1. – P. 6-11.149. D'Amato, C. Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes withgrowth and invasion of human renal cell carcinoma cells / C. D'Amato, R. Rosa, R.
Marciano etal. // Br J Cancer. – 2014. – Vol. 111. – № 6. – P. 1168-79.150. Sun, Y. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells throughGli1 activation / Y. Sun, Y. Wang, C. Fan et al. // Mol Cancer. – 2014. – Vol. 13. – P. 137.151. Das, S. The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancercells by up-regulating osteopontin / S.
Das, L. G. Harris, B. J. Metge et al. // J Biol Chem. –2009. – Vol. 284. – № 34. – P. 22888-97.152. Das, S. Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases /S. Das, J. A. Tucker, S. Khullar et al. // PLoS One. – 2012. – Vol. 7. – № 3. – P. e34374.153. Ten Haaf, A. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breastcancer is associated with unfavourable overall survival / A.
ten Haaf, N. Bektas, S. von Serenyiet al. // BMC Cancer. – 2009. – Vol. 9. – P. 298.154. Zhu, H. The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of TranscriptionFactors in Gene Regulation and Diseases / H. Zhu, H. W. Lo // Curr Genomics. – 2010. – Vol.11. – № 4. – P.
238-45.114155. Zbinden, M. NANOG regulates glioma stem cells and is essential in vivo acting in a crossfunctional network with GLI1 and p53 / M. Zbinden, A. Duquet, A. Lorente-Trigos et al. //EMBO J. – 2010. – Vol. 29. – № 15. – P. 2659-74.156. Stecca, B. Brain as a paradigm of organ growth: Hedgehog-Gli signaling in neural stem cells andbrain tumors / B.
Stecca, A. Ruiz i Altaba // J Neurobiol. – 2005. – Vol. 64. – № 4. – P. 476-90.157. Liu, S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant humanmammary stem cells / S. Liu, G. Dontu, I. D. Mantle et al. // Cancer Res. – 2006. – Vol. 66. – №12. – P. 6063-71.158. Oka, N.
VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells / N.Oka, A. Soeda, A. Inagaki et al. // Biochem Biophys Res Commun. – 2007. – Vol. 360. – № 3. –P. 553-9.159. Ricci-Vitiani, L. Tumour vascularization via endothelial differentiation of glioblastoma stem-likecells / L. Ricci-Vitiani, R.
Pallini, M. Biffoni et al. // Nature. – 2010. – Vol. 468. – № 7325. – P.824-8.160. Yoon, C. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehogsignaling promotes chemotherapy resistance / C. Yoon, D. J. Park, B. Schmidt et al. // ClinCancer Res. – 2014. – Vol. 20. – № 15. – P. 3974-88.161. Batsaikhan, B. E.
Cyclopamine decreased the expression of Sonic Hedgehog and its downstreamgenes in colon cancer stem cells / B. E. Batsaikhan, K. Yoshikawa, N. Kurita et al. / AnticancerRes. – 2014. – Vol. 34. – № 11. – P. 6339-44.162. Carmeliet, P. Angiogenesis in cancer and other diseases / P. Carmeliet, R. K. Jain // Nature. –2000. – Vol.
407. – № 6801. – P. 249-57.163. Hanna, A. Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment /A. Hanna, L. A. Shevde // Mol Cancer. – 2016. – Vol. 15. – P. 24.164. Nakamura, K. Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1and IGF-1 expression in bone-marrow derived pro-angiogenic cells / K. Nakamura, J. Sasajima,Y. Mizukami et al. // PLoS One. – 2010.
– Vol. 5. – № 1. – P. e8824.165. Mathew, E. Dosage-dependent regulation of pancreatic cancer growth and angiogenesis byhedgehog signaling / E. Mathew, Y. Zhang, A. M. Holtz et al. // Cell Rep. – 2014. – Vol. 9. – №2. – P. 484-94.166. Allen, B. L. The Hedgehog-binding proteins Gas1 and Cdo cooperate to positively regulate Shhsignaling during mouse development / B.
L. Allen, T. Tenzen, A. P. McMahon // Genes Dev. –2007. – Vol. 21. – № 10. – P. 1244-57.115167. Harris, L. G. Increased vascularity and spontaneous metastasis of breast cancer by hedgehogsignaling mediated upregulation of cyr61 / L. G. Harris, L. K. Pannell, S. Singh et al. //Oncogene.
– 2012. – Vol. 31. – № 28. – P. 3370-80.168. Carpenter, R. L. The gain-of-function GLI1 transcription factor TGLI1 enhances expression ofVEGF-C and TEM7 to promote glioblastoma angiogenesis / R. L. Carpenter, I. Paw, H. Zhu etal. // Oncotarget. – 2015. – Vol. 6. – № 26.
– P. 22653-65.169. Zhu, H. The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth / H.Zhu, R. L. Carpenter, W. Han et al. // Cancer Lett. – 2014. – Vol. 343. – № 1. – P. 51-61.170. Hsieh, A. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells /A. Hsieh, R. Ellsworth, D. Hsieh // J Cell Physiol. – 2011. – Vol. 226. – № 4. – P.
1118-27.171. Pinter, M. Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-Aexpression in hepatocellular carcinoma / M. Pinter, W. Sieghart, M. Schmid et al. // UnitedEuropean Gastroenterol J. – 2013. – Vol. 1. – № 4. – P. 265-75.172. Hong, K. D. Expression of GLI1 correlates with expression of lymphangiogenesis proteins,vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, incolorectal cancer / K. D. Hong, Y. Lee, B.
H. Kim et al. // Am Surg. – 2013. – Vol. 79. – № 2. –P. 198-204.173. Rhim, A. D. Stromal elements act to restrain, rather than support, pancreatic ductaladenocarcinoma / A. D. Rhim, P. E. Oberstein, D. H. Thomas et al. // Cancer Cell. – 2014. – Vol.25. – № 6. – P. 735-47.174. Olive, K. P. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mousemodel of pancreatic cancer / K. P. Olive, M.
A. Jacobetz, C. J. Davidson et al. // Science. – 2009.– Vol. 324. – № 5933. – P. 1457-61.175. Hwang, R. F. Inhibition of the hedgehog pathway targets the tumor-associated stroma inpancreatic cancer / R. F. Hwang, T. T. Moore, M. M. Hattersley et al. // Mol Cancer Res. – 2012.– Vol. 10. – № 9. – P. 1147-57.176. Meng, E.
The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in HumanCancer / E. Meng, A. Hanna, R. S. Samant et al. // Cancers (Basel). – 2015. – Vol. 7. – № 3. – P.1333-48.177. Kinsella, T. J. Coordination of DNA mismatch repair and base excision repair processing ofchemotherapy and radiation damage for targeting resistant cancers / T. J. Kinsella // Clin CancerRes. – 2009.
– Vol. 15. – № 6. – P. 1853-9.178. Mazumdar, T. The GLI genes as the molecular switch in disrupting Hedgehog signaling in coloncancer / T. Mazumdar, J. DeVecchio, A. Agyeman et al. // Oncotarget. – 2011. – Vol. 2. – № 8. –P. 638-45.116179. Inaguma, S. GLI1 interferes with the DNA mismatch repair system in pancreatic cancer throughBHLHE41-mediated suppression of MLH1 / S. Inaguma, M. Riku, M. Hashimoto et al.
// CancerRes. – 2013. – Vol. 73. – № 24. – P. 7313-23.180. Kudo, K. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-inducedupregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair / K.Kudo, E. Gavin, S. Das et al. // Oncogene. – 2012. – Vol. 31. – № 44. – P. 4718-24.181.
Laner-Plamberger, S. Cooperation between GLI and JUN enhances transcription of JUN andselected GLI target genes / S. Laner-Plamberger, A. Kaser, M. Paulischta et al. // Oncogene. –2009. – Vol. 28. – № 13. – P. 1639-51.182. Haar, C. P. Drug resistance in glioblastoma: a mini review / C. P. Haar, P. Hebbar, G. C. t.Wallace et al. // Neurochem Res. – 2012.